Answers are grounded in this paper and cite their sources.
Objective: To compare the reduction in ocular surface disease index (OSDI) score from baseline by using autologous serum and artificial tears in managing dry eye syndrome. Study Design: Quasi-experimental study. Setting: Department of Ophthalmology, Federal Government Polyclinic Hospital, Islamabad, Pakistan. Period: June-2025 to November-2025. Methods: A total of 70 patients with dry eye syndrome were included and divided into groups 1 and 2 without randomization in alternating fashion. Group-1 was given autologous serum eye drops for 3 months and Group-2 was given artificial tears for 3 months. Comparison of pre- and post-intervention median OSDI score within the groups was done using Wilcoxon signed rank test. Intergroup comparison of median OSDI score and median % reduction in OSDI score from baseline was done using Mann Whitney U-test. Analysis was done with SPSS software version 25. Results: Composite median age of DES sufferers was 41.50 (22.00) years. There were 41 (58.60%) male and 29 (41.40%) female patients. In Group-1, median pre-intervention OSDI, post-intervention OSDI score and % reduction in OSDI score from baseline was 61.00 (17.00), 32.00 (36.00) and 47.54 (44.76) % while in Group-2, these were 64.00 (15.00); (p = 0.400), 34.00 (12.00); (p = 0.184) and 52.50 (10.82) %; (p = 0.025), respectively. There was no significant difference of post-intervention DES severity among the study groups (p = 0.628). Conclusion: Autologous serum provides comparable results to artificial tears in dry eyes syndrome with significantly increased reduction in OSDI score.
No takes yet. Share an insight, caveat, or question.
Sahar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: